
3.55 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 2.24 Today|||52-Week Range 4.65 | -8.63% Year-to-Date |
Adma Biologics (ADMA) Gains As Market Dips: What You Should Know Sep 21 / Zacks.com - Paid Partner Content | Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? Sep 13 / Zacks.com - Paid Partner Content |
Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know Sep 14 / Zacks.com - Paid Partner Content |
Previous close | 3.49 |
Today’s open | 3.51 |
Day’s range | 3.51 - 3.60 |
Volume | 43,392 |
Average volume (3 months) | 2,079,522 |
Market cap | $789.4M |
Earnings growth (last year) | +35.11% |
Earnings growth (this year) | +75.00% |
Earnings growth (next 5 years) | +14.00% |
Revenue growth (last year) | +90.36% |
P/E ratio | NM |
Price/Sales | 4.98 |
Price/Book | 5.12 |
---- | ||
SAVACassava Sciences Inc | -0.75 | -4.21% |
BCYCBicycle Therapeutics... | -0.25 | -1.24% |
IBRXImmunitybio Inc | -0.14 | -8.70% |
Next reporting date | November 8, 2023 |
EPS forecast (this quarter) | -$0.02 |
Annual revenue (last year) | $154.1M |
Annual profit (last year) | -$65.9M |
Net profit margin | -42.77% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Ramsey, New Jersey |